The invention provides PDE9-inhibiting compounds of Formula (I),
and pharmaceutically acceptable salts thereof, wherein R
1
, R
2
, R
3
, A, and n are as defined herein. Pharmaceutical compositions containing the compounds of Formula I, and uses thereof in treating neurodegenerative and cognitive disorders, such as Alzheimer's disease and schizophrenia, are also provided.